Robert Matthew Lutz
CIK 1786203 · Chief Fin. & Operating Officer · last filed 2026-07-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.76M
Companies
3
Total Filings
14
Lifetime Open-Market Net
-$8.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SVRA | Chief Fin. & Operating Officer | 328,977 | $5.33 | $1.75M | $0 | 6 | 2026-07-24 |
| IBIO | See Remarks | 5,108 | $1.39 | $7.1K | -$8.5K | 5 | 2022-11-15 |
| Strongbridge Biopharma plc (SBBP) Delisted | Chief Financial Officer | 181,333 | $2.00 | $362.7K | $0 | 3 | 2021-02-23 |
Recent Filings · Page 2 of 2
14 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-04 | IBIO | Grant (A) | +232,000 | $0 | EDGAR |
| 2021-02-23 | Strongbridge Biopharma plc (SBBP) Delisted | Tax (F) | −6,978 | -$25.3K | EDGAR |
| 2021-01-08 | Strongbridge Biopharma plc (SBBP) Delisted | Grant (A) | +147,500 | $0 | EDGAR |
| 2020-01-29 | Strongbridge Biopharma plc (SBBP) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–14 of 14
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.